Internationally recognized investigator in translational bioinformatics and precision medicine, Joel is the Executive Vice President for Precision Health for the Mount Sinai Health System. Joel’s precision medicine work has been featured by Scientific American, CNBC, Wall Street Journal, Forbes, and other national and international media outlets.
Assistant Professor and Director of the Health Data and Design Innovation Center at the Mount Sinai School of Medicine. Noah’s research is aimed at improving decision-making in healthcare by developing and deploying novel data-driven technologies. Previously, Noah co-founded a venture-backed healthcare startup to deliver clinical decision support using practice patterns mined from the electronic medical record.
Associate Professor, Director of the Sharing Lab at the Icahn Institute for Genomics and Multiscale Biology, and Director of Democratized Health Innovation at the Institute for Next Generation Healthcare at the Mount Sinai School of Medicine. He has created several communities of practice around pivotal new technologies and emerging capabilities spanning biomedicine, biotech and health sciences.
Biomedical Software Developer at the Health Data and Design Innovation Center. He primarily works with mobile applications, but also works on decentralized applications and blockchain applications in healthcare. He was the grand prize winner of the 2017 NYC Blockchain Hackathon. Matt received his B.S. in Biomedical Engineering and M.S. in Electrical Engineering from Washington University in St. Louis.
Biomedical Software Developer at The Institute for Next Generation Healthcare at Mount Sinai. His background is from industry big data and data warehousing. Mark is currently focusing on application development, electronic health record data, and wearable technologies. In addition, Mark will be focusing on developing and implementing blockchain solutions within the healthcare space.
Herbert Irving Assitant Professor of Biomedical Informatics at Columbia University. Nick's research group is dedicated to making drugs safer through analysis of patient data and his discoveries have been featured by The New York Times, The Chicago Tribune, and The Boston Globe.
